P16 X-POCT Automatic Flow Fluorescence Immunoassay System

Portable fluorescence immunoassay system for rapid point-of-care diagnostic testing. Enables detection and quantification of biomarkers in clinical specimens through fluorescence-based immunoassay methodology. Designed for laboratory and clinical use with portable form factor for decentralized testing applications.

The Q8 Pro is a point-of-care fluorescence immunoassay analyzer designed for rapid clinical testing in laboratory and bedside settings. It performs quantitative immunoassay measurements for cardiac markers, hormones, and infectious disease detection with automated sample processing and results reporting.

POCT dry fluorescence immunoassay test kits and immunoanalyzer for rapid point-of-care diagnostics. Designed for hematology and clinical chemistry applications with integrated reagent, calibrator, and control solutions. CE and ISO 13485 certified with compatibility across leading analyzer platforms.

Fluorescence immunoassay POCT rapid diagnostic kits for point-of-care testing, enabling quick detection of biomarkers at the bedside or clinical setting. These kits utilize fluorescence technology to deliver sensitive and specific results without requiring centralized laboratory infrastructure, supporting rapid clinical decision-making.

Multi-parameter fluorescence immunoassay diagnostic test kits enabling point-of-care testing for 20+ clinical parameters. These POCT reagents provide rapid, sensitive detection across infectious disease, cardiac, and metabolic markers, supporting timely clinical decision-making in resource-limited and acute care settings.

A fluorescence-based immunoassay platform from the POCT series designed for rapid diagnostic testing. The SF-100 platform enables high-sensitivity and high-precision immunofluorescence detection for various clinical analytes and sample types.

Fluorescence quantitative immunoassay platform for in vitro diagnostic testing of infectious diseases, respiratory pathogens, and gastrointestinal markers. The system enables quantitative analysis using fluorescence immunoassay technology with Class II medical device certification across multiple regulatory markets. Supports high-throughput diagnostic workflows in clinical laboratories and reference testing facilities.

Point-of-care testing immunoassay kits enabling rapid diagnostic results at the patient bedside or clinical laboratory. These products provide quick turnaround results for common clinical markers without requiring laboratory equipment.

A portable fluorescence immunoassay analyzer for point-of-care testing (POCT) applications. This handheld device enables rapid immunoassay testing in clinical settings with micro-scale sample requirements.

A POCT-series chemiluminescence immunoassay analyzer designed for point-of-care diagnostic testing. This instrument is part of B&C Biological's POCT product line for rapid immunodiagnostic applications in clinical settings.

Clinical-grade immunoassay technologies adapted for near-patient and point-of-care settings. These systems deliver market-leading performance and reliability without compromising diagnostic accuracy in distributed testing environments.

An automated analyzer for point-of-care testing (POCT) that performs chemiluminescence immunoassays. The device is designed for immunological testing applications and is part of the company's in vitro diagnostic automation product portfolio.